A Cameroonian telehealth company won Saudi Arabia's biggest startup prize

Waspito, a Cameroonian telehealth company, won the LEAP Award at Rocket Fuel 2026 — the competition's grand prize, worth $250,000 in equity-free funding. The company was founded by Jean Lobe Lobe and launched in 2020. Its platform offers instant video consultations with doctors from a smartphone, and mobile laboratory services in which a technician collects samples at the patient's home. The stated aim is to pull the pieces of a healthcare interaction — consultation, testing, follow-up — into one place rather than leaving a patient to assemble them. Waspito has reported reaching 650,000 users across Cameroon and Côte d'Ivoire and facilitating 60,000 consultations. It raised a seed round of about $2.7m in 2022, followed by a $2.5m extension in 2023 whose backers included DP World through Newtown Partners, Saviu Ventures, AAIC Investment, Axian Ventures and CFAO's Health54, taking the total raised to roughly $5.2m. Set those two figures against each other and the reason a judging panel might reach for this company becomes clearer. A telehealth platform that has served 650,000 users on about $5.2m has kept its cost of acquisition low, which in this category usually means the product is spreading through the thing it does rather than through paid marketing. That is the number a health platform is hardest to fake on. The Francophone West and Central African market it serves has a specific shape that explains the model. Doctor density is low, specialists concentrate in a small number of cities, and the journey to a consultation is frequently the barrier rather than the fee. A video consultation removes the journey. Home sample collection removes the second journey, which is the one patients most often abandon — a test ordered and never taken is a diagnosis never made. The mobile laboratory piece is also what makes the business more defensible than a pure consultation app. Video consultation is a feature that any well-funded competitor can build. A network of technicians who will come to a house, collect a sample correctly and get it to a laboratory intact is an operational asset that takes years to assemble and does not transfer. What the award means commercially is a separate question from what it means as recognition. Equity-free capital at $250,000 is roughly a twentieth of what the company has raised to date, so its value is not primarily the money. It is the position: the grand prize at the largest technology event in the Gulf, in front of an investor room the organisers put at 1,289 investors from 1,016 firms. For a company whose current markets are Cameroon and Côte d'Ivoire, that is exposure to a capital pool it would otherwise have to travel a long way to reach. Whether it converts is the open question, and it is worth being precise about what would show it. A Gulf investor on a subsequent round, or a stated expansion into a Middle Eastern market, would indicate the prize did more than fund a quarter. Neither has been announced, and Waspito has not said what it intends to do with the money. The health economics of the region it might expand into are different enough that the model would not transport unchanged. Saudi Arabia has high doctor density, a national digital health programme and existing telemedicine provision, so the problem Waspito solves at home is not the problem it would solve here. The transferable asset is the operational one — the home collection network and the logistics behind it — rather than the consultation layer.